Viridian Therapeutics, Inc./DE Increase (Decrease) in Inventories
Viridian Therapeutics, Inc./DE (VRDN) reported Increase (Decrease) in Inventories of -$123.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2017-03-24
- Viridian Therapeutics, Inc./DE increase (decrease) in inventories for the quarter ending 2016-12-31 was $2.00K.
- Viridian Therapeutics, Inc./DE increase (decrease) in inventories for the quarter ending 2016-09-30 was -$151.00K.
- Viridian Therapeutics, Inc./DE increase (decrease) in inventories for the quarter ending 2016-06-30 was -$56.00K, a 127.18% decline year-over-year.
- Viridian Therapeutics, Inc./DE increase (decrease) in inventories for the quarter ending 2016-03-31 was $82.00K, a 45.70% decline year-over-year.
- Viridian Therapeutics, Inc./DE increase (decrease) in inventories for fiscal 2016 was -$123.00K, a 1637.50% decline from fiscal 2015.
- Viridian Therapeutics, Inc./DE increase (decrease) in inventories for fiscal 2015 was $8.00K.
- Viridian Therapeutics, Inc./DE increase (decrease) in inventories for fiscal 2014 was -$178.00K, a 195.19% decline from fiscal 2013.
- Viridian Therapeutics, Inc./DE increase (decrease) in inventories for fiscal 2013 was $187.00K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|---|---|
| 2016-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | -$149.00K derived: sum of 2 quarters · filed 2017-03-24 | -$205.00K derived: sum of 3 quarters · filed 2017-03-24 | -$123.00K 10-K · filed 2017-03-24 | ||
| 2016-09-30 | -$151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | -$207.00K derived: sum of 2 quarters · filed 2016-10-26 | -$125.00K 10-Q · filed 2016-10-26 | -$302.00K derived: sum of 4 quarters · filed 2017-03-24 | ||
| 2016-06-30 | -$56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $26.00K 10-Q · filed 2016-08-15 | -$151.00K derived: sum of 3 quarters · filed 2017-03-24 | -$323.00K derived: sum of 4 quarters · filed 2017-03-24 | ||
| 2016-03-31 | $82.00K 10-Q · filed 2016-05-16 | -$95.00K derived: sum of 2 quarters · filed 2017-03-24 | -$267.00K derived: sum of 3 quarters · filed 2017-03-24 | -$61.00K derived: sum of 4 quarters · filed 2017-03-24 | ||
| 2015-12-31 | -$177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | -$349.00K derived: sum of 2 quarters · filed 2017-03-24 | -$143.00K derived: sum of 3 quarters · filed 2017-03-24 | $8.00K 10-K · filed 2017-03-24 | ||
| 2015-09-30 | -$172.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | $34.00K derived: sum of 2 quarters · filed 2016-10-26 | $185.00K 10-Q · filed 2016-10-26 | $132.00K derived: sum of 4 quarters · filed 2016-10-26 | ||
| 2015-06-30 | $206.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $357.00K 10-Q · filed 2016-08-15 | $304.00K derived: sum of 3 quarters · filed 2016-08-15 | $343.00K derived: sum of 4 quarters · filed 2016-08-15 | ||
| 2015-03-31 | $151.00K 10-Q · filed 2016-05-16 | $98.00K derived: sum of 2 quarters · filed 2016-05-16 | $137.00K derived: sum of 3 quarters · filed 2016-05-16 | $205.00K derived: sum of 4 quarters · filed 2016-05-16 | ||
| 2014-12-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | -$14.00K derived: sum of 2 quarters · filed 2016-03-21 | $54.00K derived: sum of 3 quarters · filed 2016-03-21 | -$178.00K 10-K · filed 2016-03-21 | ||
| 2014-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $107.00K derived: sum of 2 quarters · filed 2015-11-13 | -$125.00K 10-Q · filed 2015-11-13 | -$124.58K 10-Q · filed 2014-11-14 | $22.85K derived: sum of 4 quarters · filed 2015-11-13 | |
| 2014-06-30 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | -$164.00K 10-Q · filed 2015-08-14 | -$163.50K 10-Q · filed 2014-08-14 | -$16.15K derived: sum of 3 quarters · filed 2015-08-14 | $101.44K derived: sum of 4 quarters · filed 2015-08-14 | |
| 2014-03-31 | -$232.00K 10-Q · filed 2015-05-15 | -$84.15K derived: sum of 2 quarters · filed 2015-05-15 | $33.44K derived: sum of 3 quarters · filed 2015-05-15 | |||
| 2013-12-31 | $147.85K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $265.44K derived: sum of 2 quarters · filed 2015-03-27 | $187.00K 10-K · filed 2015-03-27 | |||
| 2013-09-30 | $117.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $39.15K 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | -$78.44K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |